10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 341 filers reported holding 10X GENOMICS INC in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $631,125 | -23.6% | 15,300 | +3.4% | 1.06% | -33.3% |
| Q2 2023 | $826,432 | +3.1% | 14,800 | +3.1% | 1.59% | +10.1% |
| Q1 2023 | $801,200 | -19.2% | 14,361 | -58.8% | 1.45% | -28.7% |
| Q3 2022 | $992,000 | +59.5% | 34,848 | +155.1% | 2.03% | +199.4% |
| Q2 2022 | $622,000 | +53.6% | 13,661 | +466.8% | 0.68% | +247.2% |
| Q1 2021 | $405,000 | – | 2,410 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |